Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001013762-25-002283
Filing Date
2025-03-25
Accepted
2025-03-25 17:29:24
Documents
114
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0234724-10k_biomx.htm   iXBRL 10-K 2028260
2 DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EX ea023472401ex4-1_biomx.htm EX-4.1 18962
3 MTEC BASE AGREEMENT NO. 2019-532, DATED AS OF AUGUST 22, 2019, BY AND BETWEEN AD ea023472401ex10-34_biomx.htm EX-10.34 214993
4 BIOMX INC. INSIDER TRADING POLICY ea023472401ex19-1_biomx.htm EX-19.1 51405
5 CONSENT OF KESSELMAN & KESSELMAN ea023472401ex23-1_biomx.htm EX-23.1 2004
6 CERTIFICATION ea023472401ex31-1_biomx.htm EX-31.1 11189
7 CERTIFICATION ea023472401ex31-2_biomx.htm EX-31.2 9909
8 CERTIFICATION ea023472401ex32-1_biomx.htm EX-32.1 5319
14 GRAPHIC image_001.jpg GRAPHIC 17025
15 GRAPHIC image_002.jpg GRAPHIC 5644
16 GRAPHIC ex10-34_001.jpg GRAPHIC 8236
17 GRAPHIC ex10-34_002.jpg GRAPHIC 7035
  Complete submission text file 0001013762-25-002283.txt   9872441

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE phge-20241231.xsd EX-101.SCH 82049
10 XBRL CALCULATION FILE phge-20241231_cal.xml EX-101.CAL 67637
11 XBRL DEFINITION FILE phge-20241231_def.xml EX-101.DEF 451119
12 XBRL LABEL FILE phge-20241231_lab.xml EX-101.LAB 748583
13 XBRL PRESENTATION FILE phge-20241231_pre.xml EX-101.PRE 472491
117 EXTRACTED XBRL INSTANCE DOCUMENT ea0234724-10k_biomx_htm.xml XML 942234
Mailing Address 22 EINSTEIN ST. FLOOR 4 NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST. FLOOR 4 NESS ZIONA L3 7414003 972 723942377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

EIN.: 823364020 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38762 | Film No.: 25769444
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)